Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
33%
OVERLAP
BY WEIGHT
10
# OF OVERLAPPING
HOLDINGS
PBE
27
HOLDINGS
37%
ALSO IN BBH
BBH
26
HOLDINGS
42%
ALSO IN PBE
SECTOR DRIFT (PBE minus BBH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in BBH |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 7.5% | 6.4% | 6.4% |
|
GILEAD SCIENCES INC | 5.4% | 13.8% | 5.4% |
|
AMGEN INC | 5.1% | 15.7% | 5.1% |
|
VERTEX PHARMACEUTICALS INC | 4.1% | 8.4% | 4.1% |
|
ILLUMINA INC | 5.7% | 2.9% | 2.9% |
PBE Overweight Relative to BBH
|
ROYALTY PHARMA PLC CLASS A | 5.7% |
|
UNITED THERAPEUTICS CORP | 4.8% |
|
ANAVEX LIFE SCIENCES CORP. | 4.1% |
|
BIOMARIN PHARMACEUTICAL INC | 3.4% |
|
COLLEGIUM PHARMACEUTICAL, INC. | 3.2% |
|
HALOZYME THERAPEUTICS INC | 3.1% |
|
ACADIA PHARMACEUTICALS INC | 3.0% |
|
PROTAGONIST THERAPEUTICS, INC. | 3.0% |
|
AMICUS THERAPEUTICS INC | 2.9% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 2.9% |
PBE Underweight Relative to BBH
|
AMGEN INC | -10.5% |
|
GILEAD SCIENCES INC | -8.4% |
 |
ARGENX SE ADR | -5.6% |
|
REGENERON PHARMACEUTICALS | -5.3% |
|
IQVIA HOLDINGS INC | -5.0% |
|
VERTEX PHARMACEUTICALS INC | -4.3% |
|
NATERA INC | -4.0% |
|
INSMED INC | -3.8% |
|
BIOGEN IDEC INC | -3.4% |
 |
ICON PLC | -3.4% |